» Articles » PMID: 30585273

Neutrophil Suppresses Tumor Cell Proliferation Via Fas /Fas Ligand Pathway Mediated Cell Cycle Arrested

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2018 Dec 27
PMID 30585273
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

While neutrophils have dutifully performed their function in injury and infection, the recent works have found that cytotoxicity and/or cytostatic of neutrophils has also been observed in tumor. Till now the molecular players that participate in this neutrophils antitumoral effect remain unclear. In the current study, we find that neutrophils from healthy donors have potent suppression to tumor cell lines by physical contact. Importantly, these suppression activities seem to be cancer cell-specific which is not observed in the normal cells. Further observations show that neutrophils mediated tumor cell lines growth inhibitory effect through early cell cycle arrested. Treatment with an antagonist Fas receptor in A549 cell line or knocking out of the Fas gene in A549 cell line recovers tumor cells cycle and lessen neutrophils anti-tumor effect. The interaction between neutrophils and A549 cell line through Fas ligand /Fas regulates the expression of cell cycle checkpoint proteins, leading to early cell cycle arrest. This phenomenon is also seen in other 3 tumor cell lines. Taken together, our results identified a new role of Fas ligand /Fas interaction in neutrophils antitumoral effect in tumors via arresting cell cycle.

Citing Articles

Harnessing myeloid cells in cancer.

Park S, Pylaeva E, Bhuria V, Gambardella A, Schiavoni G, Mougiakakos D Mol Cancer. 2025; 24(1):69.

PMID: 40050933 PMC: 11887392. DOI: 10.1186/s12943-025-02249-2.


Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review).

Hou R, Wu X, Wang C, Fan H, Zhang Y, Wu H Int J Oncol. 2025; 66(4).

PMID: 40017131 PMC: 11900975. DOI: 10.3892/ijo.2025.5734.


Neutrophil Engulfment in Cancer: Friend or Foe?.

Lu T, Li W Cancers (Basel). 2025; 17(3).

PMID: 39941753 PMC: 11816126. DOI: 10.3390/cancers17030384.


Exploring the therapeutic potential of oleanolic acid and its derivatives in cancer treatment: a comprehensive review.

DMello R, Mendon V, Pai P, Das I, Sundara B 3 Biotech. 2025; 15(3):56.

PMID: 39926108 PMC: 11803024. DOI: 10.1007/s13205-025-04209-5.


Neutrophils in cancer: from biology to therapy.

Koenderman L, Vrisekoop N Cell Mol Immunol. 2024; 22(1):4-23.

PMID: 39653768 PMC: 11686117. DOI: 10.1038/s41423-024-01244-9.


References
1.
Malumbres M, Barbacid M . Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009; 9(3):153-66. DOI: 10.1038/nrc2602. View

2.
Wang X, Qin W, Xu X, Xiong Y, Zhang Y, Zhang H . Endotoxin-induced autocrine ATP signaling inhibits neutrophil chemotaxis through enhancing myosin light chain phosphorylation. Proc Natl Acad Sci U S A. 2017; 114(17):4483-4488. PMC: 5410827. DOI: 10.1073/pnas.1616752114. View

3.
Swierczak A, Mouchemore K, Hamilton J, Anderson R . Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis Rev. 2015; 34(4):735-51. DOI: 10.1007/s10555-015-9594-9. View

4.
Desbarats J, Duke R, Newell M . Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Nat Med. 1998; 4(12):1377-82. DOI: 10.1038/3965. View

5.
Takamizawa S, Okamoto S, Wen J, BISHOP W, Kimura K, Sandler A . Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing. J Pediatr Surg. 2000; 35(2):375-9. DOI: 10.1016/s0022-3468(00)90044-7. View